18 Apr 2019

MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

This alert highlights two reports of fatal adverse reactions to yellow fever vaccine and the importance of a detailed risk assessment before vaccination MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) has published an alert following two fatal adverse reactions to yellow fever vaccine. This publication reinforces the importance of a detailed individual risk assessment before administering yellow fever vaccine especially for those who may be immunocompromised or aged 60 years and older. 

NaTHNaC have been working closely with the MHRA following these two reports of fatal adverse reactions. Measures to minimise risks are being reviewed by an Expert Working Group convened by the Commission on Human Medicines and any updates will be highlighted in due course.

Resources

Hepatitis A vaccine recommendations for Turkey updated

Hepatitis A vaccine is recommended for most travellers to Turkey Read more

Zika advice for Thailand updated for pregnant women

Pregnant women are advised to avoid travel to Thailand Read more

Update to rabies risk for Estonia

NaTHNaC has reviewed and updated the rabies recommendations for Estonia Read more

Country Focus: Pakistan

Pre-travel advice for those going to Pakistan Read more
Back to Top

VIEW FULL INDEX